New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New way to target advanced breast cancers

New way to target advanced breast cancers

by Jackson LaboratoryHuman breast cancer tissue stained by immunofluorescence illustrates the interplay between secreted and surface-bound TGFβ (red) expressed by cancer cells (blue), which prime
Oncology April 14,2024
New way to target advanced breast cancers

New way to target advanced breast cancers

by Jackson LaboratoryHuman breast cancer tissue stained by immunofluorescence illustrates the interplay between secreted and surface-bound TGFβ (red) expressed by cancer cells (blue), which prime
Oncology April 14,2024
Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient
Oncology April 14,2024
Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient
Oncology April 14,2024
Startup to commercialize blood test for most major cancers

Startup to commercialize blood test for most major cancers

by Paul Tumarkin,University of ArizonaCredit: University of ArizonaWhen testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, thou
Oncology April 14,2024
Startup to commercialize blood test for most major cancers

Startup to commercialize blood test for most major cancers

by Paul Tumarkin,University of ArizonaCredit: University of ArizonaWhen testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, thou
Oncology April 14,2024
Prediagnosis exercise may reduce CV risk in breast cancer

Prediagnosis exercise may reduce CV risk in breast cancer

(HealthDay)—For women with primary breast cancer, prediagnosis exercise exposure is associated with a graded reduction in subsequent cardiovascular event (CVE) risk, according to a study published in
Oncology April 14,2024
Prediagnosis exercise may reduce CV risk in breast cancer

Prediagnosis exercise may reduce CV risk in breast cancer

(HealthDay)—For women with primary breast cancer, prediagnosis exercise exposure is associated with a graded reduction in subsequent cardiovascular event (CVE) risk, according to a study published in
Oncology April 14,2024
The sugar-attaching enzyme that defines colon cancer

The sugar-attaching enzyme that defines colon cancer

by American Society for Biochemistry and Molecular BiologyThe enzyme GalNAc-T6 is selectively up-regulated in colon adenocarcinomas, and its expression is associated with a cancer-like growth pat
Oncology April 14,2024
The sugar-attaching enzyme that defines colon cancer

The sugar-attaching enzyme that defines colon cancer

by American Society for Biochemistry and Molecular BiologyThe enzyme GalNAc-T6 is selectively up-regulated in colon adenocarcinomas, and its expression is associated with a cancer-like growth pat
Oncology April 14,2024
Discovery may lead to natural ent-kaurane diterpenoid for NK-based tumor immunotherapy

Discovery may lead to natural ent-kaurane diterpenoid for NK-based tumor immunotherapy

by Chinese Academy of SciencesCredit: KIBAs early responders in the surveillance of malignant cells, natural killer (NK) cells play a significant role in the control of transformed cells at the t
Oncology April 14,2024
Discovery may lead to natural ent-kaurane diterpenoid for NK-based tumor immunotherapy

Discovery may lead to natural ent-kaurane diterpenoid for NK-based tumor immunotherapy

by Chinese Academy of SciencesCredit: KIBAs early responders in the surveillance of malignant cells, natural killer (NK) cells play a significant role in the control of transformed cells at the t
Oncology April 14,2024
Make glasses cool with new emojis, urges UK schoolgirl

Make glasses cool with new emojis, urges UK schoolgirl

by Helen ROWEThere are currently only three emojis with glasses.British schoolgirl Lowri Moore is just 13 but has achieved a lot in her short life, championing children who like her wear glasses.Aged
Pediatrics April 14,2024
Make glasses cool with new emojis, urges UK schoolgirl

Make glasses cool with new emojis, urges UK schoolgirl

by Helen ROWEThere are currently only three emojis with glasses.British schoolgirl Lowri Moore is just 13 but has achieved a lot in her short life, championing children who like her wear glasses.Aged
Pediatrics April 14,2024
More screen time for babies could slow development

More screen time for babies could slow development

by Cara MurezToo much screen time can lead to developmental delays in babies, researchers say.When 1-year-olds viewed screens for more than four hours a day, they had delays in communication and probl
Pediatrics April 14,2024
More screen time for babies could slow development

More screen time for babies could slow development

by Cara MurezToo much screen time can lead to developmental delays in babies, researchers say.When 1-year-olds viewed screens for more than four hours a day, they had delays in communication and probl
Pediatrics April 14,2024
Infants are not egocentric: Study finds they trust other people's attention more than their own observations

Infants are not egocentric: Study finds they trust other people's attention more than their own observations

by University of CopenhagenIn the initial trials, 8-month-old children had to follow a ball being moved by either a conveyor belt or a hand. In both cases, the children were able to figure out wh
Pediatrics April 14,2024
Infants are not egocentric: Study finds they trust other people's attention more than their own observations

Infants are not egocentric: Study finds they trust other people's attention more than their own observations

by University of CopenhagenIn the initial trials, 8-month-old children had to follow a ball being moved by either a conveyor belt or a hand. In both cases, the children were able to figure out wh
Pediatrics April 14,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com